Health & Life Sciences

Publications

09/30/20 – Article

Richard B. Davis

"Drug Manufacturers Cut Off 340B Pricing for Contract Pharmacies"State Bar of Wisconsin's Health Law BlogRichard B. DavisHealth care providers who qualify for preferential pricing through the Health Resources and Services Administration 340B Drug Pricing Program are bracing themselves for further reductions in the drugs they can dispense through their contract pharmacy networks. Many manufacturers have announced changes... Read More

09/29/20 – Newsletter Importation of Pharmaceuticals From Canada Under the Section 804 Importation Program Health & Life Sciences Alert Theodore M. Sullivan

07/28/20 – Newsletter Part 2 Modernization Underway: Revised Rule Released While We Await CARES Act Rulemaking Health & Life Sciences Alert Meghan C. O'Connor, Sarah A. Erdmann

07/21/20 – Newsletter The Laws, They Are A-Changin: Indiana Health Care-Related Laws Update, July 2020 Health & Life Sciences Alert Katea M. Ravega, Edward L. Holloran, III, Cory J. Kopitzke, Hunter G. DeKoninck, Shamika L. Mazyck, Ryan L. Torres

07/01/20 – Newsletter Oregon Publishes Final Rule Requiring Pharmacies to Provide Prescription Label Readers Health & Life Sciences Katea M. Ravega, Shamika L. Mazyck

04/16/20 – Newsletter DEA Temporarily Removes the 'Five Percent Rule' Health & Life Sciences Alert Edward D. Rickert, Hunter G. DeKoninck, Christopher T. Dang

04/10/20 – Newsletter HIPAA Flexibility for COVID-19 Testing Sites Health & Life Sciences Meghan C. O'Connor, Rachel H. Weiss

04/09/20 – Newsletter DEA Issues Final Order Increasing APQs for Certain Controlled Substances Health & Life Sciences Alert Edward D. Rickert, Hunter G. DeKoninck

04/02/20 – Newsletter Changes to Pharmacy Rules Governing Automated Storage and Delivery Systems Due to COVID-19 Health & Life Sciences Alert Edward D. Rickert

03/20/20 – Newsletter Board of Pharmacy Responses to COVID-19 Outbreak - UPDATED Heath & Life Sciences Alert Nicholas H. Meza

03/13/20 – Newsletter USP Appeals Panel Grants Appeals to USP 795 and 797, Denies Appeal to USP 825 Health & Life Sciences Alert Cory J. Kopitzke, Brenda M. Maloney Shafer

03/12/20 – Newsletter Planning for Preparedness and Response: COVID-19 Response for the Health and Life Sciences Industry Health & Life Sciences Alert Meghan C. O'Connor, Simone Colgan Dunlap, Nicholas H. Meza

03/05/20 – Newsletter Key Takeaways of the DEA's 2019 National Drug Threat Assessment Health & Life Sciences Alert Hunter G. DeKoninck, Edward D. Rickert

02/03/20 – Newsletter GAO Report Suggests Increased Oversight of 340B Program To Be or Not to 340B Blog Brenda M. Maloney Shafer, Richard B. Davis

01/14/20 – Newsletter The Latest on Proposed Changes to Wisconsin Patient Counseling Rule That Will Impact Mail Order Pharmacies: Board Submits Final Rule Draft Health & Life Sciences Alert Susan B. Trujillo, Richard B. Davis, Christopher M. Guthrie

12/04/19 – Newsletter Massachusetts Drug Discount Provision Set to Expire January 1, 2020 Health & Life Sciences Alert Simone Colgan Dunlap, Leah Tinney

11/25/19 – Newsletter Board’s Economic Impact Analysis Disputes Industry Submissions, Board Advances Proposed Rule Without Changes Health & Life Sciences Alert Susan B. Trujillo, Richard B. Davis

11/19/19 – Newsletter Results of Economic Impact Discussion: The Latest on Proposed Changes to Wisconsin Patient Counseling Rule That Will Impact Mail Order Pharmacies Health & Life Sciences Alert Susan B. Trujillo, Richard B. Davis

11/06/19 – Newsletter Answers to Questions About USP's Notice of Intent to Revise New Compounding Standards Health & Life Science Alert Sarah E. Coyne, Brenda M. Maloney Shafer, Cory J. Kopitzke

11/05/19 – Newsletter The Latest on Proposed Changes to Wisconsin Patient Counseling Rule That Will Impact Mail Order Pharmacies: Potential Relief for Mail Order Pharmacies? Health & Life Sciences Alert Susan B. Trujillo, Richard B. Davis

10/30/19 – Newsletter The Latest on Proposed Changes to Wisconsin Patient Counseling Rule That Will Impact Mail Order Pharmacies Health & Life Sciences Alert Susan B. Trujillo, Richard B. Davis

10/14/19 – Newsletter Applications Now Available for Alaska's New Licensing Categories and Prescription Standards Health & Life Sciences Alert Susan B. Trujillo, Nicholas H. Meza, Richard B. Davis

09/24/19 – Newsletter USP Publishes Notice of Intent to Revise New Compounding Standards Health & Life Sciences Alert Brenda M. Maloney Shafer, Cory J. Kopitzke

09/18/19 – Newsletter New PBM State Laws Indicate a Shifting Battlefront over 340B Program Drug Pricing To Be or to Not to 340B Blog Brenda M. Shafer, Richard B. Davis

09/12/19 – Newsletter Washington Eliminates Technician to Pharmacist Ratio Health & Life Sciences Alert Susan B. Trujillo, Nicholas H. Meza, Luis J. Lanz

08/19/19 – Newsletter 2018 Farm Bill, Technician Ratios, and Hazardous Waste Rules: Hot Topics in Pharmacy Law Health & Life Sciences Alert Anne M. O'Brien, Nicholas H. Meza, Jacqueline M. Vidmar

08/13/19 – Newsletter Alabama Designates Gabapentin as a Schedule V Drug Health & Life Sciences Alert Susan B. Trujillo, Nicholas H. Meza, Luis J. Lanz

08/06/19 – Newsletter Interesting 340B Takeaways from 2020 OPPS Proposed Rule To Be or Not to 340B Blog Brenda M. Maloney Shafer, Richard B. Davis, Benjamin A. Lockwood

04/29/19 – Newsletter Alabama Board of Pharmacy Imposing 3:1 Technician to Pharmacist Ratio on Non-Resident Pharmacies Health & Life Sciences Alert Nicholas H. Meza, Roger N. Morris, Simone Colgan Dunlap

02/01/19 – Article "New York Court Overturns Multiple Convictions Against Pharmacist" American Society for Pharmacy Law By Roger N. Morris, Nicholas H. Meza and Luis J. Lanz

• Page 1 of 2
• Next